Grant Report on SCH: Personalized Depression Treatment Supported by Mobile Sensor Analytics
Open Access
- 1 January 2020
- journal article
- research article
- Published by Hapres in Journal of Psychiatry and Brain Science
- Vol. 5 (2)
Abstract
We report on the newly started project “SCH: Personalized Depression Treatment Supported by Mobile Sensor Analytics”. The current best practice guidelines for treating depression call for close monitoring of patients, and periodically adjusting treatment as needed. This project will advance personalized depression treatment by developing a system, DepWatch, that leverages mobile health technologies and machine learning tools. The objective of DepWatch is to assist clinicians with their decision making process in the management of depression. The project comprises two studies. Phase I collects sensory data and other data, e.g., clinical data, ecological momentary assessments (EMA), tolerability and safety data from 250 adult participants with unstable depression symptomatology initiating depression treatment. The data thus collected will be used to develop and validate assessment and prediction models, which will be incorporated into DepWatch system. In Phase II, three clinicians will use DepWatch to support their clinical decision making process. A total of 128 participants under treatment by the three participating clinicians will be recruited for the study. A number of new machine learning techniques will be developed.Keywords
This publication has 44 references indexed in Scilit:
- Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones– the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trialBMC Psychiatry, 2014
- Mobile phones as medical devices in mental disorder treatment: an overviewPersonal and Ubiquitous Computing, 2014
- Harnessing Context Sensing to Develop a Mobile Intervention for DepressionJournal of Medical Internet Research, 2011
- Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depressionJournal of Affective Disorders, 2011
- Personalized Medicine for Depression: Can We Match Patients With Treatments?American Journal of Psychiatry, 2010
- International Consensus Statement on Major Depressive DisorderThe Journal of Clinical Psychiatry, 2010
- Does early improvement triggered by antidepressants predict response/remission? — Analysis of data from a naturalistic study on a large sample of inpatients with major depressionJournal of Affective Disorders, 2009
- Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive DisorderThe Journal of Clinical Psychiatry, 2009
- The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiological Psychiatry, 2003
- The PHQ-9Journal of General Internal Medicine, 2001